After nearly two years at the helm of the FDA, Scott Gottlieb is resigning at the beginning of April.
For the last two years, Scott Gottlieb missed a lot of time with his wife and three daughters — back-to-school nights, school plays and parent-teacher conferences.
The commute didn't bother him so much until late last year when he was on a call with a U.S. senator and his other line kept ringing. It was his wife; she was hit by a car while walking in a strip mall parking lot and slightly fractured her knee. He flew home that day, but there was no quick way to get to her between the flight and hour-long drive home from the airport.
That's essentially what he told his staff when he resigned March 5; he wanted to spend more time with his family. The 46-year-old still has a full career in front of him. He's worked at the FDA multiple times, invested in health-care companies as a venture capitalist and written about health policy at the conservative think tank, the American Enterprise Institute. He denied knowing what he's going to do next.
He'll step down before the policy is finalized or implemented. It's one of a number of initiatives he advanced that he leaves unfinished. He says he would have liked the tobacco policies to be further along, though he's"confident" they will get out. "That last week is going to be hard. The first week after I announced, it was difficult," Gottlieb said."I was very emotional because in some respects, I'm walking away from the best job I'll ever have. That's hard to do."
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
You might want to check the expiration date on your sunscreen before you bring it to the beachFDA Commissioner Scott Gottlieb may have announced his resignation earlier this month, but he's still bringing forth new health regulations for the country.
Leer más »
FDA Commissioner Calls for Tighter Standard for Approval of New Opioid DrugsFDA Commissioner Scott Gottlieb is proposing that the agency take the novel step of approving new opioid painkillers only if they show comparative advantages over existing drugs.
Leer más »
Health officials want next FDA chief to crack down on teen vaping of e-cigarettes
Leer más »
FDA takes up decades-long debate over breast implant safety
Leer más »
Flood of products containing marijuana extract puts FDA in a bindCBD is blurring the line between a drug and a dietary supplement and testing how much the government can police health claims
Leer más »
Axsome Therapeutics shares soar after FDA grants breakthrough designation to depression drugAxsome Therapeutics Inc. shares jumped 7% in premarket trade Wednesday, after the U.S. Food and Drug Administration granted breakthrough therapy designation...
Leer más »
FDA proposes rule to notify women with dense breasts of higher cancer risk and imprecise mammogramsThe Food and Drug Administration is proposing a rule that would require doctors to tell women how dense breasts may influence the accuracy of their breast cancer screenings and encourage women with dense breasts to talk to a doctor.
Leer más »
FDA proposes mammography rule to provide women with information about breast densityThe FDA proposed requiring mammogram providers to notify women with dense breast tissue about how the condition could affect the accuracy of their mammograms and recommend they talk with doctors about whether they should have more tests to check for cancer
Leer más »
Device-safety experts to FDA: Make data publicMedical device safety researchers are calling on the FDA to release hundreds of thousands of hidden injury and malfunction reports related to about 100 medical devices.
Leer más »
FDA proposes mammography rule to provide women with breast-density informationThe Food and Drug Administration proposes updating of 25-year-old mammography standards to help ensure women get breast density information
Leer más »